RTOG.ORG: Keyword Density Checker

Total words: 887 | 2-word phrases: 231 | 3-word phrases: 251 | 4-word phrases: 258

PAGE INFO

Title	Try to keep the title under 60 characters (12 characters) Home \| RTOG
Description	Try to keep the meta description between 50 - 160 characters (14 characters) Description...
Keywords	Meta keywords are not recommended anymore (14 characters) RTOG
H1	H1 tag on the page (4 characters) News

#	Keyword	Frequency	Density
1	cancer read more	3	1.20%
2	interview rtog 3521	2	0.80%
3	recurrent metastatic nasopharyngeal	2	0.80%
4	improving outcomes for	2	0.80%
5	outcomes for cancer	2	0.80%
6	participate in rtog	2	0.80%
7	the rtog foundation	2	0.80%
8	nasopharyngeal cancer read	2	0.80%
9	metastatic nasopharyngeal cancer	2	0.80%
10	combination toripalimab and	2	0.80%
11	in recurrent metastatic	2	0.80%
12	investigator interview rtog	2	0.80%
13	april 01 2024	2	0.80%
14	01 2024 principal	2	0.80%
15	chemotherapy in recurrent	2	0.80%
16	principal investigator interview	2	0.80%
17	clinical trials rtog	2	0.80%
18	news april 01	2	0.80%
19	by enrolling in	1	0.40%
20	enrolling in one	1	0.40%
21	an rtog study	1	0.40%
22	in one of	1	0.40%
23	one of our	1	0.40%
24	in rtog research	1	0.40%
25	of our studies	1	0.40%
26	our studies partners	1	0.40%
27	rtog research to	1	0.40%
28	research to participate	1	0.40%
29	to participate as	1	0.40%
30	participate as an	1	0.40%

#	Keyword	Frequency	Density
1	april 01 2024 principal	2	0.78%
2	chemotherapy in recurrent metastatic	2	0.78%
3	improving outcomes for cancer	2	0.78%
4	nasopharyngeal cancer read more	2	0.78%
5	metastatic nasopharyngeal cancer read	2	0.78%
6	recurrent metastatic nasopharyngeal cancer	2	0.78%
7	in recurrent metastatic nasopharyngeal	2	0.78%
8	news april 01 2024	2	0.78%
9	investigator interview rtog 3521	2	0.78%
10	of our studies partners	1	0.39%
11	collaborator or by enrolling	1	0.39%
12	rtog foundation as either	1	0.39%
13	foundation as either a	1	0.39%
14	as either a member	1	0.39%
15	either a member site	1	0.39%
16	a member site an	1	0.39%
17	industry collaborator or by	1	0.39%
18	or by enrolling in	1	0.39%
19	one of our studies	1	0.39%
20	rtog research to participate	1	0.39%
21	in rtog research to	1	0.39%
22	participate in rtog foundation	1	0.39%
23	participate in rtog research	1	0.39%
24	by enrolling in one	1	0.39%
25	enrolling in one of	1	0.39%
26	in one of our	1	0.39%
27	in rtog foundation as	1	0.39%
28	can participate in rtog	1	0.39%
29	to participate as an	1	0.39%
30	from industry and federally	1	0.39%
31	to improving outcomes for	1	0.39%
32	for cancer patients through	1	0.39%
33	cancer patients through the	1	0.39%
34	conduct of practice changing	1	0.39%
35	of practice changing clinical	1	0.39%
36	practice changing clinical trials	1	0.39%
37	changing clinical trials rtog	1	0.39%
38	clinical trials rtog collaborates	1	0.39%
39	trials rtog collaborates with	1	0.39%
40	us contact us patient	1	0.39%

#	URL	Whois	Check
1	https://rtog-patientregistration.acr.org/	Whois	acr.org
2	http://	Whois	.
3	https://www.acr.org/	Whois	acr.org
4	https://www.nrgoncology.org/	Whois	nrgoncology.org
5	https://www.acr.org/Privacy	Whois	acr.org